Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Jenna Phillips

Advertisement

Articles by Jenna Phillips

Phillips and Moen

Operating Models for Successful DOL Engagement

ByJenna Phillips,Erik Moen
March 26th 2024

How life sciences companies can design an effective operating model for DOL engagements.

Moen Phillips

Influencer Marketing, Digital Opinion Leaders

ByJenna Phillips,Erik Moen
March 25th 2024

How consumer goods marketing approaches can support pharmaceutical and life sciences companies in their growth this year.

Advertisement

Latest Updated Articles

  • Phillips and Moen
    Operating Models for Successful DOL Engagement

    March 26th 2024



Advertisement
Advertisement

Trending on PharmExec

1

Elicio Therapeutics’ Shares Drop Following Announcement of Phase II Trial Results

2

Partnering in Non-Opioids: Q&A with Dr. Edward Littler and Dave Watson

3

Novavax's Strategy Across Commercial, R&D, and Partnerships

4

Pharma Roundup: FDA Approves Truqap Plus Abiraterone and Prednisone, FDA Approves Keytruda and Keytruda Qlex Each in Combination with Welireg

5

Pharmaceutical Executive Daily: FDA Approves Two Indications of Keytruda in Combination with Welireg

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us